FindTrial
Sign In

Clinical observation of Lennox-Gastaut Syndrome Treated by Transcranial Direct Current Stimulation with New Targets

Clinical observation of Lennox-Gastaut Syndrome Treated by Transcranial Direct Current Stimulation with New Targets

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015720
Enrollment
Unknown
Registered
2018-04-16
Start date
2018-04-04
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

Group of transcranial direct current stimulation:Transcranial direct current stimulation
group of Sham stimulation:sham stimulation

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis as Lennox-Gastaut syndrome. 2. The dose of applied antiepileptic drugs did not change for 8 weeks before the baseline period and throughout the duration of the study. 3. The patient has a history of epilepsy for at least 1 year. 4. Gender is unlimited, age is higher than or equal to 2 years.

Exclusion criteria

Exclusion criteria: 1. status epilepticus; 2. heart attack; 3. progressive brain disease or systemic disease; 4. Severe heart, lung, liver, kidney and other physical diseases or severe neuropsychiatric diseases; 5. with cardiac pacemakers, vagus nerve stimulators or metal implanted in the body.

Design outcomes

Primary

MeasureTime frame
Seizure frequency;—

Secondary

MeasureTime frame
EEG epileptiform discharge;Quality of Life Questionnaire;—

Countries

China

Contacts

Public ContactWang Yuping

Xuanwu Hospital Capital Medical University

wangyuping01@sina.cn+86 010-83198273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026